Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DJDawgon Jan 03, 2023 6:01pm
220 Views
Post# 35201699

RE:RE:RE:Commercialization in 2026??

RE:RE:RE:Commercialization in 2026??
I agree with skys1. TLT got dinged in past for making speculative statements about things in the future. Something to do with RDW and a laser that he thought would rock the world. As such I think they say 2026 to avoid any over-promising as in the past.

We all hope for some partner or jv connection as this would bring in money for a while, raise awareness to new buyers and give them connections to run the trials faster (1b for ruthenium?).

My big hope has been that RDW has been doing only one thing as business development lead and that is planning big things after he takes over mid Feb. I suspect any big announcements will happen after that. I doubt many of the knowledgable holders will be selling shares between now ad mid Feb. In the absence of many sellers I predict a slow drift up like we saw today. IMO

I have hope for the networking abilities of TLT based on the connection with Li Ka Shing as that was a unique arrangement for a small biotech to get. It makes me hopeful that someone at TLT knows how to work the phones and build relationships that lead to something.
<< Previous
Bullboard Posts
Next >>